Bayer Operating Income 2012-2025 | BAYRY

Bayer operating income for the twelve months ending December 31, 2025 was $-1.219B, a 1485.95% increase year-over-year.

  • Bayer annual operating income for 2025 was $-1.219B, a 1485.95% increase from 2024.
  • Bayer annual operating income for 2024 was $-0.077B, a 111.6% decline from 2023.
  • Bayer annual operating income for 2023 was $0.662B, a 91.03% decline from 2022.

Bayer Operating Income 2012-2025 | BAYRY

  • Bayer annual operating income for 2025 was $-1.219B, a 1485.95% increase from 2024.
  • Bayer annual operating income for 2024 was $-0.077B, a 111.6% decline from 2023.
  • Bayer annual operating income for 2023 was $0.662B, a 91.03% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Innoviva (INVA)$1.8B